Bio-Rad shares rise ahead of Q3 earnings release
BIO Bio-Rad Laboratories Inc
$388.31 +1.77%
View chart & analysis → - 1Bio-Rad shares have risen 9.5% since the recent update.
- 2The consensus revenue for Bio-Rad in Q3 is approximately $661.9 million.
- 3The consensus earnings per share (EPS) for Bio-Rad in Q3 is $2.61.
So what's the key point?
Bio-Rad shares have recently risen by about 9.5%. Expectations are growing ahead of the upcoming Q3 earnings release predicted by experts.
Source Earnings Whispers · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.